The Effects of Blackcurrant Supplementation on Eye Health
NCT ID: NCT04775654
Last Updated: 2022-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
57 participants
INTERVENTIONAL
2021-03-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Eye and Carotenoid Augmentation Research and Evaluation (EyeCARE)
NCT06848101
Blueberry Effects on Dark Vision and Glare Recovery
NCT01942746
Carotenoid Supplementation and Normal Ocular Health
NCT02147171
Effect of Oral Curcumin Supplementation in Dry Age-related Macular Degeneration (AMD) Patients
NCT04590196
Carotenoid Supplementation and Retinal Health in Healthy Adults
NCT07314411
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supplement
Participants consume 455mg of blackcurrant extract standardized to contain 50mg anthocyanins in a 2-capsule dose for 70 days.
Blackcurrant
Two capsules containing 455mg of CurrantCraft 11% black currant extract.
Placebo
Participants consume 2 capsules of microcrystalline cellulose for 70 days.
Placebo
Two capsules containing an inert material.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blackcurrant
Two capsules containing 455mg of CurrantCraft 11% black currant extract.
Placebo
Two capsules containing an inert material.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 30-60
* Lives in the United States
* Employed full time in an online work environment OR enrolled full time in an online learning environment (average of 6+ hours per day)
* Ability to understand study instructions
* Ability to provide informed consent
* Residence within 100 miles of the study center
Exclusion Criteria
* Uncontrolled hypertension (i.e. systolic/diastolic blood pressure \> 140/90)
* Uncontrolled diabetes (i.e. fasting blood glucose \>180mg/dl)
* Any blood clotting disorder
* Ocular disease
* Best corrected visual acuity \<20/30
* Cataracts
* Renal disease
* Active hepatitis or cirrhosis
* Acute or chronic infectious disease
* Pregnant
* Breastfeeding
* Currently trying to conceive
* Surgical or other invasive procedure planned within the intervention period
30 Years
60 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Artemis International
UNKNOWN
Nutraceuticals Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jessie R Hawkins, PhD
Role: PRINCIPAL_INVESTIGATOR
Franklin Health Research & Education Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Franklin Health Research Center
Franklin, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-02-7800
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.